Most lately, it has been recognized that conolidine and the above derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to your big range of endogenous opioids. Not like most opioid receptors, this receptor functions as a scavenger and isn't going to activate a next